| Typicality: | 0.380 |
| Saliency: | 0.408 |
| in people with alzheimer’s disease | 8 | other |
| according to results from a study | 4 | other |
| significantly | 3 | degree |
| drug → improve → cognitive function | 18 |
| drug → enhance → cognitive function | 11 |
| drug → improve → cognitive performance | 8 |
| drug → boost → cognitive function | 5 |
| drug → improve → cognitive abilities | 5 |
| drug → enhance → cognitive abilities | 5 |
| drug → enhance → cognitive functions | 4 |
| drug → boost → cognitive ability | 4 |
| drug → improve → cognitive functions | 4 |
| negative | neutral | positive |
| 0.094 | 0.410 | 0.497 |
| Raw frequency | 64 |
| Normalized frequency | 0.408 |
| Modifier score | 0.633 |
| Perplexity | 29.036 |